| Literature DB >> 6404949 |
H Hambley, J F Davidson, I D Walker, M Small, C R Prentice.
Abstract
Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6404949 PMCID: PMC498289 DOI: 10.1136/jcp.36.5.574
Source DB: PubMed Journal: J Clin Pathol ISSN: 0021-9746 Impact factor: 3.411